Intuitive Surgical (NASDAQ:ISRG) Raised to Buy at Wall Street Zen

Intuitive Surgical (NASDAQ:ISRG) was upgraded by equities researchers at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Saturday.

A number of other equities research analysts have also recently commented on ISRG. Evercore ISI increased their price objective on shares of Intuitive Surgical from $470.00 to $550.00 and gave the company an “in-line” rating in a research note on Tuesday, July 8th. Royal Bank Of Canada reaffirmed an “outperform” rating and issued a $615.00 price target on shares of Intuitive Surgical in a report on Tuesday, August 19th. Wells Fargo & Company raised their price objective on shares of Intuitive Surgical from $559.00 to $599.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 23rd. Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research report on Saturday, September 27th. Finally, UBS Group upped their target price on Intuitive Surgical from $547.00 to $585.00 and gave the company a “neutral” rating in a research note on Wednesday, July 23rd. Fourteen investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $594.19.

Intuitive Surgical Price Performance

NASDAQ ISRG opened at $452.35 on Friday. The business has a 50 day moving average price of $463.55 and a 200 day moving average price of $500.11. The company has a market capitalization of $162.16 billion, a P/E ratio of 63.09, a PEG ratio of 4.74 and a beta of 1.61. Intuitive Surgical has a 1-year low of $425.00 and a 1-year high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same quarter in the prior year, the company earned $1.78 earnings per share. Intuitive Surgical’s revenue was up 21.4% compared to the same quarter last year. On average, research analysts expect that Intuitive Surgical will post 6.43 earnings per share for the current fiscal year.

Insider Transactions at Intuitive Surgical

In other news, Director Amy L. Ladd sold 335 shares of the stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director owned 739 shares in the company, valued at approximately $325,669.91. This trade represents a 31.19% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 45,224 shares of company stock valued at $21,716,492 over the last quarter. Company insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

A number of large investors have recently added to or reduced their stakes in ISRG. Aaron Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock valued at $1,374,000 after acquiring an additional 19 shares in the last quarter. Crown Wealth Group LLC lifted its stake in shares of Intuitive Surgical by 4.8% in the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock worth $218,000 after acquiring an additional 20 shares in the last quarter. FSM Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 3.8% in the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock valued at $270,000 after purchasing an additional 20 shares during the last quarter. CFO4Life Group LLC grew its stake in Intuitive Surgical by 4.8% during the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock valued at $216,000 after purchasing an additional 20 shares in the last quarter. Finally, J. W. Coons Advisors LLC increased its holdings in Intuitive Surgical by 1.4% during the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock worth $741,000 after purchasing an additional 20 shares during the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.